EXPRESSION OF HSP 90, PTEN AND BCL-2 IN CONJUNCTIVAL MELANOMA.
Résumé
Background: In conjunctival melanoma little is known about the tumour biology and protein-expression patterns. In this study we analysed the expression of the antiapoptotic oncoprotein Bcl-2, the tumour-suppressor PTEN, and the heat-shock-protein HSP-90 in conjunctival melanoma (CoM) and conjunctival nevi (CoN) by immunohistochemistry (IHC). Material and Methods: IHC was performed on 70 samples of CoM and 12 samples of CoN. Expression-patterns between the diagnosis-groups were compared. ROC-analysis was performed to reveal diagnostic value of the antigens. Results: HSP-90 (p=<0.0001) and PTEN (p=0.001) showed potential to differentiate between CoM and CoN. Bcl-2 expression was higher in CoM than in CoN (p=0.04) . The loss of nuclear PTEN expression was more pronounced in the malignant melanomas than in CoN (p=0.02). Tumours located at unfavourable sites (fornix, palpebral conjunctiva, caruncle) that had developed recurrences expressed almost twice as much HSP-90 than recurrence-free tumours. Conclusions: Conjunctival melanocytes differentially express Bcl-2, HSP-90 and PTEN depending on their entity. HSP-90- and PTEN-expression may add relevant information for the differentiation between conjunctival melanoma and nevi.
Origine : Fichiers produits par l'(les) auteur(s)
Loading...